Abstract:Rationale: Myocardial injury triggers intense oxidative stress, inflammatory response, and cytokine release, which are essential for myocardial repair and remodeling. Excess reactive oxygen species (ROS) scavenging and inflammation elimination have long been considered to reverse myocardial injuries. However, the efficacy of traditional treatments (antioxidant, anti-inflammatory drugs and natural enzymes) is still poor due to their intrinsic defects such as unfavorable pharmacokinetics and bioavailability, low biological stability, and potential side effects. Nanozyme represents a candidate to effectively modulate redox homeostasis for the treatment of ROS related inflammation diseases. Methods: We develop an integrated bimetallic nanozyme derived from metal-organic framework (MOF) to eliminate ROS and alleviate inflammation. The bimetallic nanozyme (Cu-TCPP-Mn) is synthesized by embedding manganese and copper into the porphyrin followed by sonication, which could mimic the cascade activities of superoxide dismutase (SOD) and catalase (CAT) to transform oxygen radicals to hydrogen peroxide, followed by the catalysis of hydrogen peroxide into oxygen and water. Enzyme kinetic analysis and oxygen-production velocities analysis were performed to evaluate the enzymatic activities of Cu-TCPP-Mn. We also established myocardial infarction (MI) and myocardial ischemia-reperfusion (I/R) injury animal models to verify the ROS scavenging and anti-inflammation effect of Cu-TCPP-Mn. Results: As demonstrated by kinetic analysis and oxygen-production velocities analysis, Cu-TCPP-Mn nanozyme possesses good performance in both SOD- and CAT-like activities to achieve synergistic ROS scavenging effect and provide protection for myocardial injury. In both MI and I/R injury animal models, this bimetallic nanozyme represents a promising and reliable technology to protect the heart tissue from oxidative stress and inflammation-induced injury, and enables the myocardial function to recover from otherwise severe damage. Conclusions: This research provides a facile and applicable method to develop a bimetallic MOF nanozyme, which represents a promising alternative to the treatment of myocardial injuries.

Superoxide dismutase mimetic nanozymes attenuate cardiac microvascular ischemia–reperfusion injury associated with hyperhomocysteinemia

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

Superoxide Dismutase‐Loaded Nanoparticles Attenuate Myocardial Ischemia‐Reperfusion Injury and Protect against Chronic Adverse Ventricular Remodeling

Cu-Doping Layered Double Hydroxides Nanozyme Integrated with Nitric Oxide Donor for Enhanced Antioxidant Therapy in Retinopathy

MOF-derived bimetallic nanozyme to catalyze ROS scavenging for protection of myocardial injury

Biominerallized Noble Metal-Based RuO<sub>2</sub> Nanozymes Against Myocardial Ischemic/Reperfusion Injury

Myocardial Cell Mitochondria-Targeted Mesoporous Polydopamine Nanoparticles Eliminate Inflammatory Damage in Cardiovascular Disease

Protective effects of Pt-N-C single-atom nanozymes against myocardial ischemia-reperfusion injury

Ultra‐Small Copper‐Based Multienzyme‐Like Nanoparticles Protect Against Hepatic Ischemia‐Reperfusion Injury Through Scavenging Reactive Oxygen Species in Mice

An antioxidant system through conjugating superoxide dismutase onto metal-organic framework for cardiac repair

Induction of apoptosis and autosis in cardiomyocytes by the combination of homocysteine and copper via NOX-mediated p62 expression

Myocardial-Targeting Tannic Cerium Nanocatalyst Attenuates Ischemia/Reperfusion Injury

Anti-Oxidant and Anti-Endothelial Dysfunctional Properties of Nano-Selenium in Vitro and in Vivo of Hyperhomocysteinemic Rats

Cu,Zn Dopants Boost Electron Transfer of Carbon Dots for Antioxidation.

An Antioxidant Nanozyme for Targeted Cardiac Fibrosis Therapy Post Myocardial Infarction

A metal-organic cage-derived cascade antioxidant nanozyme to mitigate renal ischemia-reperfusion injury

A Redox Modulatory Sod Mimetic Nanozyme Prevents The Formation of Cytotoxic Peroxynitrite And Improves Nitric Oxide Bioavailability in Human Endothelial Cells

Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases

Protective effects of cysteine analogues on acute myocardial ischemia: Novel modulators of endogenous H2S production

HIF-1α Preconditioning Potentiates Antioxidant Activity in Ischemic Injury: the Role of Sequential Administration of Dihydrotanshinone I and Protocatechuic Aldehyde in Cardioprotection

A Self‐Sustaining Antioxidant Strategy for Effective Treatment of Myocardial Infarction